WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Heron Therapeutics revenue was $144.29M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $40.8M, up 24.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HRTX annual revenue was $144.3M, with 13.6% growth year-over-year.

HRTX past revenue growth

How has HRTX's revenue growth performed historically?

Company
13.57%
Industry
511.06%
Market
20.87%
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HRTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HRTX revenue history

Current Revenue
$144.3M
Current Earnings
-$13.6M
Current Profit Margin
-9.4%

Be the first to know when HRTX announces revenue.

HRTX Revenue History By Year

HRTX Yearly RevenueHRTX RevenueHRTX ChangeHRTX Revenue Growth
2024-12-31$144.29M$17.24M+13.57%
2023-12-31$127.04M$19.37M+17.99%
2022-12-31$107.67M$21.33M+24.70%
2021-12-31$86.35M-$2.29M-2.59%
2020-12-31$88.64M-$57.33M-39.28%
2019-12-31$145.97M$68.49M+88.41%
2018-12-31$77.47M$46.71M+151.81%
2017-12-31$30.77M$29.49M+2,305.55%
2016-12-31$1.28MN/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00-$646.00k-100.00%
2011-12-31$646.00k-$655.00k-50.35%
2010-12-31$1.30M$40.00k+3.17%
2009-12-31$1.26M$892.00k+241.73%
2008-12-31$369.00k-$43.00k-10.44%
2007-12-31$412.00kN/AN/A
2006-12-31$0.00-$5.39M-100.00%
2005-12-31$5.39M-$13.00k-0.24%
2004-12-31$5.40M$556.00k+11.47%
2003-12-31$4.85M$178.00k+3.81%
2002-12-31$4.67M$1.41M+43.03%
2001-12-31$3.27M-$101.00k-3.00%
2000-12-31$3.37M-$1.33M-28.33%
1999-12-31$4.70M$1.62M+52.77%
1998-12-31$3.07M-$14.13M-82.13%
1997-12-31$17.21M-$453.96k-2.57%
1996-12-31$17.66M$1.55M+9.64%
1995-12-31$16.11M$223.75k+1.41%
1994-12-31$15.88MN/AN/A

1 of 3

Heron Therapeutics Revenue FAQ

What was HRTX's revenue last quarter?

On Invalid Date, Heron Therapeutics (NASDAQ: HRTX) reported Q4 2024 revenue of $40.78 million up 19.13% year over year. In the same quarter last year, Heron Therapeutics's revenue was $34.23 million.

What was Heron Therapeutics's revenue in 2024?

Heron Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $144.29 million, a 13.57% increase year over year.

How much does Heron Therapeutics make in a day?

Based on Heron Therapeutics annual revenue for the past five years, HRTX makes an average of $303,553.42 per day.

What was Heron Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Heron Therapeutics's revenue has grown 13.57% year over year. This is 497.49 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Heron Therapeutics's revenue in the past year totaled $144.29 million.

How much does Heron Therapeutics make in a year?

Heron Therapeutics's revenue by year for the past five years is:
  • Heron Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $144.29 million, a 13.57% increase year over year.
  • Heron Therapeutics's annual revenue for Dec 31, 2023 was $127.04 million, a 17.99% increase from 2022.
  • Heron Therapeutics's annual revenue for 2022 was $107.67 million, a 24.7% increase from 2021.
  • Heron Therapeutics's annual revenue for 2021 was $86.35 million, a 2.59% decrease from 2020.
  • Heron Therapeutics's annual revenue for 2020 was $88.64 million, a 39.28% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.